Identification and Quantitation of Leukocyte Populations in Human Kidney Tissue by Multi-parameter Flow Cytometry

Katrina Kildey1,2, Becker M P Law1,2,3, Kimberly A Muczynski4

  • 1Conjoint Kidney Research Laboratory, Pathology Queensland, Brisbane, Queensland, Australia.

Bio-Protocol
|August 16, 2021
PubMed

Insights

This study introduces a new flow cytometry method to precisely identify and count immune cells in kidney biopsies, improving diagnosis for kidney diseases like acute kidney injury (AKI) and chronic kidney disease (CKD). This advanced technique overcomes limitations of older methods for better characterization of immune cell populations.

Area of Science:

  • Nephrology
  • Immunology
  • Biotechnology

Background:

  • Inflammatory immune cells are implicated in the pathology of acute kidney injury (AKI) and chronic kidney disease (CKD).
  • Current immunohistochemical (IHC) techniques limit the precise identification and characterization of distinct leukocyte populations in human kidney biopsies.
  • Existing methods struggle to combine multiple markers needed to define specific immune cell subsets.

Purpose of the Study:

  • To develop and validate a multi-parameter, flow cytometry-based approach for identifying and quantifying immune cell populations in human kidney biopsies.
  • To overcome the limitations of IHC for detailed immune cell profiling in kidney disease.

Main Methods:

  • Fresh human kidney tissue is processed into a single-cell suspension.
  • Cells are labeled with antibody panels targeting specific leukocyte markers.
  • Multi-parameter flow cytometry is used for acquisition and analysis of immune cell subpopulations.

Main Results:

  • The developed flow cytometry approach enables accurate detection and quantitation of diverse leukocyte subpopulations from a single kidney biopsy specimen.
  • This method allows for the use of comprehensive panels of cell-specific markers, surpassing IHC limitations.
  • The technique provides a robust platform for immune cell enumeration in kidney disease.

Conclusions:

  • The novel flow cytometry technique represents a significant advancement in identifying and enumerating immune cell subpopulations in human kidney diseases.
  • This method offers a powerful complement to traditional histopathological examinations of kidney biopsies.
  • Accurate immune cell characterization can enhance understanding and management of kidney diseases.